Analysts' ratings for Alignment Healthcare (NASDAQ:ALHC) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 4 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Alignment Healthcare, presenting an average target of $24.17, a high estimate of $30.00, and a low estimate of $20.00. Witnessing a positive shift, the current average has risen by 23.44% from the previous average price target of $19.58.
Analyzing Analyst Ratings: A Detailed Breakdown
The analysis of recent analyst actions sheds light on the perception of Alignment Healthcare by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| John Stansel | JP Morgan | Raises | Overweight | $26.00 | $23.00 |
| Ryan Langston | TD Cowen | Raises | Buy | $25.00 | $18.50 |
| Kevin Caliendo | UBS | Raises | Neutral | $21.00 | $18.00 |
| Jessica Tassan | Piper Sandler | Raises | Overweight | $30.00 | $20.00 |
| Lisa Gill | JP Morgan | Raises | Overweight | $23.00 | $20.00 |
| John Stansel | JP Morgan | Raises | Overweight | $20.00 | $18.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Alignment Healthcare. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Alignment Healthcare compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Alignment Healthcare's stock. This comparison reveals trends in analysts' expectations over time.
Capture valuable insights into Alignment Healthcare's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Alignment Healthcare analyst ratings.
All You Need to Know About Alignment Healthcare
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Understanding the Numbers: Alignment Healthcare's Finances
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Alignment Healthcare displayed positive results in 3M. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately 43.51%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Alignment Healthcare's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 0.38%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.46%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Alignment Healthcare's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.35% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 2.04, Alignment Healthcare faces challenges in effectively managing its debt levels, indicating potential financial strain.
The Basics of Analyst Ratings
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.